MabVax Therapeutics Holdings, Juno Therapeutics, Memorial Sloan Kettering deal

MabVax, Memorial Sloan Kettering Cancer Center and Juno partnered to develop chimeric antigen receptor (CAR) T cell therapeutics for cancer. MabVax will supply antibody-targeting sequences derived fro...